Endoscopic ultrasound and fine-needle aspiration for pancreatic cancer

Michael B. Wallace, Timothy Woodward, Massimo Raimondo

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background: Accurate staging of pancreatic cancer is essential for surgical planning, and identification of locally advanced and metastatic disease that is incurable by surgery. Advances in EUS, CT, and PET have improved the accuracy of staging and reduced the number of incomplete surgical resections. Tissue acquisition is necessary in non-surgical cases when chemoradiotherapy is considered. The complex regional anatomy of the pancreas makes cytologic diagnosis of malignancy at this region difficult without exploratory surgery. Although CT-guided fine-needle aspiration (FNA) is used for this purpose, reports of an increased risk of peritoneal dissemination of cancer cells and a false negative rate of nearly 20% makes this a less than ideal choice. The ability to position the EUS-transducer in direct proximity to the pancreas by means of stomach and the duodenum, combined with the use of FNA, increases the specificity of EUS in detecting pancreatic malignancies. Methods: The current literature regarding the accuracy of EUS with FNA in the evaluation of pancreatic cancer is reviewed. Results: EUS accuracy for tumor (T) staging ranges from approximately 78-94% and nodal (N) stage accuracy between 64 and 82%. EUS also enables FNA of lesions that are too small to be identified by CT or MRI, or too close to vascular structures to safely allow percutaneous biopsy. The accuracy for detecting invasion into the superior mesenteric artery and vein is lower than that for detecting portal or splenic vein invasion, especially for large tumors. EUS permits delivery of localized therapy such as celiac plexus neurolysis for pain control and direct intralesional injection of antitumor therapy. Conclusions: EUS in combination with FNA is a highly accurate method of preoperative staging of pancreatic cancer especially those too small to characterize by CT or MRI, and has the ability to obtain cytological confirmation.

Original languageEnglish (US)
JournalDigestive Endoscopy
Volume16
Issue numberSUPPL. 2
DOIs
StatePublished - 2004

Fingerprint

Fine Needle Biopsy
Pancreatic Neoplasms
Aptitude
Pancreas
Neoplasms
Regional Anatomy
Celiac Plexus
Intralesional Injections
Splenic Vein
Mesenteric Veins
Superior Mesenteric Artery
Neoplasm Staging
Chemoradiotherapy
Portal Vein
Transducers
Duodenum
Blood Vessels
Stomach
Biopsy
Pain

Keywords

  • Endosonography
  • Fine needle aspiration
  • Pancreatic neoplasms

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Endoscopic ultrasound and fine-needle aspiration for pancreatic cancer. / Wallace, Michael B.; Woodward, Timothy; Raimondo, Massimo.

In: Digestive Endoscopy, Vol. 16, No. SUPPL. 2, 2004.

Research output: Contribution to journalArticle

Wallace, Michael B. ; Woodward, Timothy ; Raimondo, Massimo. / Endoscopic ultrasound and fine-needle aspiration for pancreatic cancer. In: Digestive Endoscopy. 2004 ; Vol. 16, No. SUPPL. 2.
@article{eb039764e5df43579247060f26fe8cf5,
title = "Endoscopic ultrasound and fine-needle aspiration for pancreatic cancer",
abstract = "Background: Accurate staging of pancreatic cancer is essential for surgical planning, and identification of locally advanced and metastatic disease that is incurable by surgery. Advances in EUS, CT, and PET have improved the accuracy of staging and reduced the number of incomplete surgical resections. Tissue acquisition is necessary in non-surgical cases when chemoradiotherapy is considered. The complex regional anatomy of the pancreas makes cytologic diagnosis of malignancy at this region difficult without exploratory surgery. Although CT-guided fine-needle aspiration (FNA) is used for this purpose, reports of an increased risk of peritoneal dissemination of cancer cells and a false negative rate of nearly 20{\%} makes this a less than ideal choice. The ability to position the EUS-transducer in direct proximity to the pancreas by means of stomach and the duodenum, combined with the use of FNA, increases the specificity of EUS in detecting pancreatic malignancies. Methods: The current literature regarding the accuracy of EUS with FNA in the evaluation of pancreatic cancer is reviewed. Results: EUS accuracy for tumor (T) staging ranges from approximately 78-94{\%} and nodal (N) stage accuracy between 64 and 82{\%}. EUS also enables FNA of lesions that are too small to be identified by CT or MRI, or too close to vascular structures to safely allow percutaneous biopsy. The accuracy for detecting invasion into the superior mesenteric artery and vein is lower than that for detecting portal or splenic vein invasion, especially for large tumors. EUS permits delivery of localized therapy such as celiac plexus neurolysis for pain control and direct intralesional injection of antitumor therapy. Conclusions: EUS in combination with FNA is a highly accurate method of preoperative staging of pancreatic cancer especially those too small to characterize by CT or MRI, and has the ability to obtain cytological confirmation.",
keywords = "Endosonography, Fine needle aspiration, Pancreatic neoplasms",
author = "Wallace, {Michael B.} and Timothy Woodward and Massimo Raimondo",
year = "2004",
doi = "10.1111/j.1443-1661.2004.00427.x",
language = "English (US)",
volume = "16",
journal = "Digestive Endoscopy",
issn = "0915-5635",
publisher = "Wiley-Blackwell",
number = "SUPPL. 2",

}

TY - JOUR

T1 - Endoscopic ultrasound and fine-needle aspiration for pancreatic cancer

AU - Wallace, Michael B.

AU - Woodward, Timothy

AU - Raimondo, Massimo

PY - 2004

Y1 - 2004

N2 - Background: Accurate staging of pancreatic cancer is essential for surgical planning, and identification of locally advanced and metastatic disease that is incurable by surgery. Advances in EUS, CT, and PET have improved the accuracy of staging and reduced the number of incomplete surgical resections. Tissue acquisition is necessary in non-surgical cases when chemoradiotherapy is considered. The complex regional anatomy of the pancreas makes cytologic diagnosis of malignancy at this region difficult without exploratory surgery. Although CT-guided fine-needle aspiration (FNA) is used for this purpose, reports of an increased risk of peritoneal dissemination of cancer cells and a false negative rate of nearly 20% makes this a less than ideal choice. The ability to position the EUS-transducer in direct proximity to the pancreas by means of stomach and the duodenum, combined with the use of FNA, increases the specificity of EUS in detecting pancreatic malignancies. Methods: The current literature regarding the accuracy of EUS with FNA in the evaluation of pancreatic cancer is reviewed. Results: EUS accuracy for tumor (T) staging ranges from approximately 78-94% and nodal (N) stage accuracy between 64 and 82%. EUS also enables FNA of lesions that are too small to be identified by CT or MRI, or too close to vascular structures to safely allow percutaneous biopsy. The accuracy for detecting invasion into the superior mesenteric artery and vein is lower than that for detecting portal or splenic vein invasion, especially for large tumors. EUS permits delivery of localized therapy such as celiac plexus neurolysis for pain control and direct intralesional injection of antitumor therapy. Conclusions: EUS in combination with FNA is a highly accurate method of preoperative staging of pancreatic cancer especially those too small to characterize by CT or MRI, and has the ability to obtain cytological confirmation.

AB - Background: Accurate staging of pancreatic cancer is essential for surgical planning, and identification of locally advanced and metastatic disease that is incurable by surgery. Advances in EUS, CT, and PET have improved the accuracy of staging and reduced the number of incomplete surgical resections. Tissue acquisition is necessary in non-surgical cases when chemoradiotherapy is considered. The complex regional anatomy of the pancreas makes cytologic diagnosis of malignancy at this region difficult without exploratory surgery. Although CT-guided fine-needle aspiration (FNA) is used for this purpose, reports of an increased risk of peritoneal dissemination of cancer cells and a false negative rate of nearly 20% makes this a less than ideal choice. The ability to position the EUS-transducer in direct proximity to the pancreas by means of stomach and the duodenum, combined with the use of FNA, increases the specificity of EUS in detecting pancreatic malignancies. Methods: The current literature regarding the accuracy of EUS with FNA in the evaluation of pancreatic cancer is reviewed. Results: EUS accuracy for tumor (T) staging ranges from approximately 78-94% and nodal (N) stage accuracy between 64 and 82%. EUS also enables FNA of lesions that are too small to be identified by CT or MRI, or too close to vascular structures to safely allow percutaneous biopsy. The accuracy for detecting invasion into the superior mesenteric artery and vein is lower than that for detecting portal or splenic vein invasion, especially for large tumors. EUS permits delivery of localized therapy such as celiac plexus neurolysis for pain control and direct intralesional injection of antitumor therapy. Conclusions: EUS in combination with FNA is a highly accurate method of preoperative staging of pancreatic cancer especially those too small to characterize by CT or MRI, and has the ability to obtain cytological confirmation.

KW - Endosonography

KW - Fine needle aspiration

KW - Pancreatic neoplasms

UR - http://www.scopus.com/inward/record.url?scp=10044234904&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10044234904&partnerID=8YFLogxK

U2 - 10.1111/j.1443-1661.2004.00427.x

DO - 10.1111/j.1443-1661.2004.00427.x

M3 - Article

AN - SCOPUS:10044234904

VL - 16

JO - Digestive Endoscopy

JF - Digestive Endoscopy

SN - 0915-5635

IS - SUPPL. 2

ER -